WuXi to build dedicated vaccine facility, but who’s the client?

WuXi to build dedicated vaccine facility, but who’s the client?

WuXi Biologics says its vaccine joint venture has a new client and a 20-year arrangement it says should be worth about $3 billion. (WuXi Biologics).

Share this:
May 24, 2019 / Pharma News